Concordant with our results, increasing PASP and the presence of PH were previously independently associated with a higher risk of death in CKD patients [33], as well as in end-stage renal disease patients [34], reinforcing pulmonary hypertension as a key risk factor for mortality in this patient population. Here, CPB1 is linked to pulmonary hypertension.